Skip to main content

SugarBud Craft Growers Corp. (SBUDF)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
24.5Poor

ValueMarkers Composite Index

Top 0%#44,706 of 44,707

DCF data not available

Piotroski
0/9
Weak
Beneish
-
Altman
-
DCF Value
-
N/A
ROIC
-
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

SugarBud Craft Growers Corp. (SBUDF) — VMCI valuation read

SBUDF screens at VMCI 25/100, a 26-point gap below the Healthcare sector median (50). For a mid-cap SugarBud Craft Growers Corp. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

SBUDF has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: SBUDF trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -0.1x leaves covenant headroom, which sets the rate-cycle exposure for SugarBud Craft Growers Corp..

SBUDF fell 1.0% over the trailing 7 days, with a -6.0% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in SBUDF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.